Wei Xing

5.1k total citations · 1 hit paper
89 papers, 3.7k citations indexed

About

Wei Xing is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Wei Xing has authored 89 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 26 papers in Physiology and 20 papers in Molecular Biology. Recurrent topics in Wei Xing's work include Asthma and respiratory diseases (20 papers), Mast cells and histamine (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (10 papers). Wei Xing is often cited by papers focused on Asthma and respiratory diseases (20 papers), Mast cells and histamine (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (10 papers). Wei Xing collaborates with scholars based in China, United States and Italy. Wei Xing's co-authors include K. Frank Austen, Joshua A. Boyce, Yoshihide Kanaoka, Akiko Maekawa, Xiang Xu, Michael F. Gurish, Wei Guo, Howard R. Katz, Weian Zeng and Biao Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Wei Xing

84 papers receiving 3.7k citations

Hit Papers

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xing China 37 1.2k 1.1k 991 522 450 89 3.7k
Frank A. Redegeld Netherlands 41 2.0k 1.7× 1.8k 1.6× 1.2k 1.2× 938 1.8× 335 0.7× 154 5.2k
Martin Eigenthaler Germany 39 490 0.4× 1.5k 1.4× 948 1.0× 534 1.0× 660 1.5× 83 4.9k
Benito Yard Germany 40 820 0.7× 1.3k 1.2× 1.1k 1.1× 167 0.3× 1.1k 2.5× 190 5.0k
Li Ma China 40 446 0.4× 1.7k 1.6× 592 0.6× 316 0.6× 748 1.7× 172 4.9k
Barbara Mroczko Poland 40 849 0.7× 1.5k 1.4× 978 1.0× 157 0.3× 700 1.6× 286 5.2k
Albert Amberger Austria 32 1.1k 0.9× 1.9k 1.7× 257 0.3× 174 0.3× 371 0.8× 81 4.0k
Laurent Audoly United States 38 949 0.8× 1.8k 1.6× 691 0.7× 196 0.4× 352 0.8× 69 5.9k
Daniel Sedding Germany 36 852 0.7× 1.9k 1.8× 398 0.4× 203 0.4× 771 1.7× 137 4.8k
Alice Johnson United States 36 856 0.7× 1.6k 1.5× 727 0.7× 327 0.6× 324 0.7× 80 4.2k
Riccardo Bertini Italy 35 2.0k 1.7× 1.2k 1.1× 327 0.3× 254 0.5× 249 0.6× 75 4.2k

Countries citing papers authored by Wei Xing

Since Specialization
Citations

This map shows the geographic impact of Wei Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xing more than expected).

Fields of papers citing papers by Wei Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xing. The network helps show where Wei Xing may publish in the future.

Co-authorship network of co-authors of Wei Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xing. A scholar is included among the top collaborators of Wei Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xing. Wei Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaoyu, Shuo Yao, Wanyan Wang, et al.. (2025). Inhalable pH-responsive charge-reversal polymer-small interfering RNA polyplexes for directed gene therapy of anaplastic lymphoma kinase fusion-positive lung cancer. Journal of Controlled Release. 381. 113644–113644. 4 indexed citations
3.
Zhang, Huiping, et al.. (2024). The effect of cardiovascular disease on the perioperative period of radical surgery in elderly rectal cancer. BMC Gastroenterology. 24(1). 256–256.
4.
He, Min, Xiang Ao, Yu Yang, et al.. (2024). Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10. Neoplasia. 58. 101065–101065. 4 indexed citations
7.
Wan, Weijun, Xiang Ao, Quan Chen, et al.. (2022). METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Molecular Cancer. 21(1). 60–60. 276 indexed citations breakdown →
8.
Li, Yujuan, Dongtai Chen, Hanbing Wang, et al.. (2021). Intravenous versus Volatile Anesthetic Effects on Postoperative Cognition in Elderly Patients Undergoing Laparoscopic Abdominal Surgery. Anesthesiology. 134(3). 381–394. 58 indexed citations
9.
Qi, Zhenhua, Yan Fang, Dongtai Chen, et al.. (2020). Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma. Bioscience Reports. 40(10). 61 indexed citations
10.
Yan, Yan, Jiahao Pan, Yonghua Chen, et al.. (2020). Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma. Cancer Communications. 40(12). 694–710. 52 indexed citations
11.
Guo, Wei, Wei Qiu, Xiang Ao, et al.. (2020). Low‐concentration DMSO accelerates skin wound healing by Akt/mTOR‐mediated cell proliferation and migration in diabetic mice. British Journal of Pharmacology. 177(14). 3327–3341. 28 indexed citations
12.
Liang, Shengxiang, Haoyue Deng, Shili Liu, et al.. (2019). Competency building for lay health workers is an intangible force driving basic public health services in Southwest China. BMC Health Services Research. 19(1). 596–596. 17 indexed citations
13.
Laidlaw, Tanya M., Neil Bhattacharyya, Wei Xing, et al.. (2012). Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 119(16). 3790–3798. 195 indexed citations
14.
Yuan, Hongfeng, Hong Huang, Xiangyun Li, et al.. (2012). A Dual AP-1 and SMAD Decoy ODN Suppresses Tissue Fibrosis and Scarring in Mice. Journal of Investigative Dermatology. 133(4). 1080–1087. 15 indexed citations
15.
Xing, Wei. (2011). Quercetin inhibits inducible NO synthase overexpression against sepsis-induced myocardial depression. Zhongguo yaolixue tongbao. 1 indexed citations
16.
Paruchuri, Sailaja, Hiroyuki Tashimo, Chunli Feng, et al.. (2009). Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor. The Journal of Experimental Medicine. 206(11). 2543–2555. 201 indexed citations
17.
Mathias, Clinton B., Eva‐Jasmin Freyschmidt, T. G. Jones, et al.. (2009). IgE Influences the Number and Function of Mature Mast Cells, but Not Progenitor Recruitment in Allergic Pulmonary Inflammation. The Journal of Immunology. 182(4). 2416–2424. 47 indexed citations
18.
Breslow, Rebecca G., et al.. (2009). Inhibition of Th2 Adaptive Immune Responses and Pulmonary Inflammation by Leukocyte Ig-Like Receptor B4 on Dendritic Cells. The Journal of Immunology. 184(2). 1003–1013. 12 indexed citations
19.
Balestrieri, Barbara, Akiko Maekawa, Wei Xing, et al.. (2009). Group V Secretory Phospholipase A2 Modulates Phagosome Maturation and Regulates the Innate Immune Response against Candida albicans. The Journal of Immunology. 182(8). 4891–4898. 65 indexed citations
20.
Zhou, Joseph S., Wei Xing, Daniel S. Friend, K. Frank Austen, & Howard R. Katz. (2007). Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis. The Journal of Experimental Medicine. 204(12). 2797–2802. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026